Skip to main content
. 2014 Dec;26(6):339–346. doi: 10.11919/j.issn.1002-0829.214037

Table 4.

Results of repeated measures ANOVA of pre- and post-treatment assessment of measures in patients treated for 8 weeks with olanzapine, quetiapine, or aripiprazole (n=50 for each group)

Measure factor F p
fasting blood
glucose
time 3.37 0.069
group 4.89 0.009
time*group 2.63 0.075
triglyceride time 33.76 <0.001
group 2.69 0.071
time*group 3.39 0.036
total cholesterol time 3.22 0.075
group 3.70 0.027
time*group 1.22 0.299
low-density
lipoprotein
time 0.62 0.432
group 1.90 0.153
time*group 1.01 0.369
high-density
lipoprotein
time 32.74 <0.001
group 0.66 0.517
time*group 7.90 0.001
PANSS total score time 1005.70 <0.001
group 0.77 0.465
time*group 1.40 0.249
PANSS positive
symptom score
time 467.32 <0.001
group 0.780 0.461
time*group 1.20 0.305
PANSS negative
symptom score
time 471.54 <0.001
group 1.89 0.155
time*group 0.72 0.490
PANSS general
psychopathology
score
time 859.83 <0.001
group 0.67 0.512
time*group 2.78 0.065

PANSS, Positive and Negative Syndrome Scale